These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3535197)

  • 1. [A comparative study of Unixan administered once daily and Theo-Dur administered twice daily].
    Dahl R; Pedersen B
    Ugeskr Laeger; 1986 Sep; 148(40):2548-51. PubMed ID: 3535197
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
    Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
    Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined theophylline/beta-agonists maintenance therapy in chronic asthma.
    Eriksson NE; Haglind K; Ewald U
    Eur J Respir Dis; 1983 Apr; 64(3):172-7. PubMed ID: 6132832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once daily Theo-Dur in morning dippers.
    van der Vet AP; Quaedvlieg M; Greve LH
    Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):258-64. PubMed ID: 3410602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study comparing Pro-Vent and phyllocontin in stable asthmatics.
    Sivananthan N; Kana D; Winson MD; Roberts KN
    Br J Clin Pract; 1988 Dec; 42(12):498-500. PubMed ID: 3076785
    [No Abstract]   [Full Text] [Related]  

  • 6. Controlled-release theophylline and proxyphylline in asthmatics: a comparative study.
    Mosbech H; Paulsen H; Søborg M
    Pharmatherapeutica; 1984; 3(9):626-30. PubMed ID: 6374684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of once-daily Uniphyl tablets compared with twice-daily Theo-Dur tablets in elderly patients with chronic airflow obstruction.
    Rivington RN; Calcutt L; Hodder RV; Stewart JH; Aitken TL
    Am J Med; 1988 Jul; 85(1B):48-53. PubMed ID: 3041826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
    Menendez R; Kelly HW; Howick J; McWilliams BC
    Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline.
    Neuenkirchen H; Wilkens JH; Oellerich M; Sybrecht GW
    Eur J Respir Dis; 1985 Mar; 66(3):196-204. PubMed ID: 3884358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA; Kisicki J; Straughn AB
    Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience with theophylline in slow-release form (Theo-dur)].
    Jørstad SO; Omenaas E
    Tidsskr Nor Laegeforen; 1982 May; 102(13):747-9. PubMed ID: 6760450
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of sustained release theophylline (Pro-Vent), in asthma.
    Wallis PJ; Joy M; Hughes DT; Empey DW
    Br J Clin Pract; 1985 Sep; 39(9):341-5. PubMed ID: 3904796
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily].
    Baronti A; Verdiani P; Di Carlo S
    Clin Ter; 1987 Sep; 122(6):437-40. PubMed ID: 2972456
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trial of a sustained release theophylline tablet in adult asthmatics.
    Dhand R; Malik SK; Garg SK; Bhutani JK; Swaminathan S
    Indian J Chest Dis Allied Sci; 1986; 28(4):212-21. PubMed ID: 3301644
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind study comparing the effectiveness of cromolyn sodium and sustained-release theophylline in childhood asthma.
    Furukawa CT; Shapiro GG; Bierman CW; Kraemer MJ; Ward DJ; Pierson WE
    Pediatrics; 1984 Oct; 74(4):453-9. PubMed ID: 6435085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polysomnographic measurements in early and late administration (18.00 vs. 22.00 hours) of retarded theophylline in bronchial asthma].
    Rühle KH; Horn H; Hagenmeier A; Würtemberger G; Schmitz-Schumann M; Matthys H
    Prax Klin Pneumol; 1987 May; 41(5):180-6. PubMed ID: 3299354
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of sustained-release terbutaline and ordinary terbutaline in bronchial asthma.
    Eriksson NE; Haglind K; Ljungholm K
    Br J Dis Chest; 1982 Apr; 76(2):202-4. PubMed ID: 7046782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of once daily extended-release theophylline in decreasing the use of inhaled beta 2-agonists in stable, mild-to-moderate asthma patients.
    Edwards TB; Dockhorn RJ; Wagner DE; Fiddes RA; Grossman J; Menendez R; Southern DL; Cefali EA; Hassanein RS
    Ann Allergy Asthma Immunol; 1995 Nov; 75(5):409-16. PubMed ID: 7583862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of nocturnal bronchial asthma: comparison of various doses of retard theophylline].
    Dorow P; Steinijans VW
    Prax Klin Pneumol; 1987 Oct; 41(10):442-4. PubMed ID: 3325964
    [No Abstract]   [Full Text] [Related]  

  • 20. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
    Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.